by Peter Ciszewski | Feb 24, 2021
Eric Wallace, MD, University of Alabama at Birmingham (UAB) Medical Director of Telehealth, Director of the UAB Home Dialysis Program, and co-director of the UAB Fabry Disease Clinic, discusses concerns some have about clinical trials for Fabry disease. Fabry...
by Peter Ciszewski | Feb 23, 2021
Siddhee A. Sahasrabudhe, MS, PhD Student of Pharmacology at UMN’s Center of Orphan Drug Research, discusses research on the potential interactions between an oral Gaucher disease treatment and an investigational COVID-19 therapy. Gaucher disease is a rare...
by Peter Ciszewski | Feb 22, 2021
Marsha Lanes, MS, CGC, of the National Organization of Rare Disorders (NORD), talks about the many activities the organization has planned for Rare Disease Day – February 28th. As Ms. Lanes explains, numerous events are planned, including social media...
by Peter Ciszewski | Feb 19, 2021
Reena Kartha, PhD, Associate Director of Translational Pharmacology at UMN’s Center of Orphan Drug Research (CODR), discusses research being done at CODR. As Dr. Kartha explains, her primary interest is in inherited metabolic disorders such as Gaucher disease....
by Peter Ciszewski | Feb 18, 2021
Dustin Armstrong, PhD, president of Parasail, LLC, talks about the drug, VAL-1221, for the treatment of Pompe disease. Pompe disease is a lysosomal disorder that leads to reduced levels of acid alpha-glucosidase (GAA), which in turn leads to a buildup of...
